drugset / Trial / NCT00497653
Oral Administration of DCI to Women With PCOS
Phase 2/3
Terminated
13 enrolled
Virginia Commonwealth University
National Institutes of Health (NIH) · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
To determine if oral DCI administration to women with PCOS increases the total DCI content in urine and blood, and, if so, if that change is accompanied by i) an increase in DCI-IPG release in blood (as determined by bioactivity) during an oral glucose challenge and ii) an increase in whole-body insulin sensitivity.
Timeline
- Start
- 2001-02
- Primary completion
- 2007-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DCI | Unknown | 1200 mg | Oral |